Role of somatostatin receptor SSRT5-AS1 in predicting biomarkers of primary androgen deprivation therapy on prostate cancer in Indonesian population

• Main Authors: Soerohardjo, Indrawarman, Widodo, Irianiwati, Zulfiqqar, Andy, Heriyanto, Didik Setyo, Anwar, Sumadi Lukman
• Format: Article PeerReviewed
• Language: English
• Published: Malaysian Medical Association 2022
• Subjects: Oncology and Carcinogenesis; Cancer Diagnosis
• Online Access: https://repository.ugm.ac.id/284019/1/v77-Supp-1-2022.pdf; https://repository.ugm.ac.id/284019/; https://www.e-mjm.org/2022/v77s1/v77-Supp-1-2022.pdf
• Institution: Universitas Gadjah Mada

Introduction: Androgen deprivation therapy (ADT) has been the pivotal strategy for treating advanced prostate cancers. Despite the high efficacy of ADT in prohibiting tumor growth, >50% cases of prostate cancer will develop into an aggressive variant known as castration resistant prostate cancer...